has grown to 62% for the year. china, the portion in blue, 4% to 23%. the red part shrank from 15% to just 4. we talk with the ceo of u.s. antibiotics, only licensed u.s. manufacturer of amoxicillin brand products, he says other countries allow medications at very low costs, squeezed out american companies in the race to the bottom for prices. just in the area of amoxicillin, china, the chinese government made a very conscious decision to invest heavily in developing very large production facilities in china. so they drove a lot of companies that were in the united states producing amoxicillin and those companies went out of business. for a number of reasons, but i think primarily it was just the